Chest pain is one of the most common reasons adults in the United States visit the emergency department, leading to more than 7 million patient encounters each year.

Sold as Verquvo, the medication can help patients reduce their risk of cardiovascular death or hospitalization for heart failure.

The study’s authors explored data from more than 28,000 women, focusing on the impact of dozens of biomarkers. 

Abbott described the update as "critically important," and the American College of Cardiology expressed relief that some proposed changes did not actually end up happening. 

Physicians may want to think twice before prescribing certain medications, including drugs for pain or depression, to some female patients, the authors observed. 

The authors examined data from more than 1.2 million patients, tracking individuals who had previously been hospitalized for heart failure and then returned later due to COVID-19. 

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 

AI melanoma detectors that equaled or bettered dermatologists in clinical trials have stumbled on the way to the real world of patient care.